Our preliminary studies indicate that these general DNA binding patterns are also conserved in the case of MYCN, the expression of which is largely confined to cell lines derived from neuroblastomas and a limited number of other cancers (Figure S11, Supporting Information). The gene discussed is MYCN; the disease is neuroblastoma.